Viemed Healthcare, Inc. has filed an 8-K report with the SEC on March 16, 2026, which includes an investor presentation detailing the company's current financial performance and strategic outlook. The report highlights a 21% year-over-year growth in net revenues, reaching a record $270 million, alongside a 20% increase in Adjusted EBITDA, totaling $61 million. The company also reported a 32% growth in diluted EPS, marking the ninth consecutive year of positive net income. The investor presentation emphasizes the company's robust growth strategy, which includes geographic expansion and diversification into women's health and sleep therapy services. Viemed's operational model focuses on home-based clinical care, which has proven effective in reducing hospitalizations and improving patient outcomes. The company is well-positioned to capitalize on regulatory tailwinds favoring home-based care, with a strong balance sheet and no net debt, providing significant flexibility for future growth initiatives. The presentation is available on the company's website, reflecting its commitment to transparency and investor engagement.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.